Jan 2017 $18 M No. 6 $10 to $50 million 7
Cardiodx Inc.: Raise no. 6, Jan 2017 × Investors in this round 7 investors had bought by the notice of Jan 18, 2017: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $18 M of $42 M offered; $24 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: Sale and issuance of (i) Series 1-A Preferred Stock, (ii) Series 1-B Preferred Stock, and (iii) Common Stock issuable upon conversion of Series 1-A Preferred Stock and Series 1-B Preferred Stock. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Duane G. Williams · Executive Officer Jim G. Wingrove · Executive Officer Khushro F. Mehta · Executive Officer, Director Mark G. Monane · Executive Officer Susan G. Daniels · Executive Officer Tim G. Henn · Executive Officer Ajit G. Singh · Director David L. Levison · Director Hongjie G. Hu · Director Patrick G. Enright · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Proceeds will be used for general corporate purposes.”Signed by Khushro Mehta, President and CEO. Source: SEC Form D, newest notice filed Jan 18, 2017. Read the notice at the SEC .
equity SEC Jun 2015 $12 M No. 5 $10 to $50 million 15
Cardiodx Inc.: Raise no. 5, Jun 2015 × Investors in this round 15 investors had bought by the notice of Feb 22, 2016: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $12 M of $26 M offered; $13 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: Sale and issuance of Series DD-2 Preferred Stock and the underlying Common Stock issuable upon conversion thereof. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice David L. Levison · Executive Officer, Director Gwen R. Carscadden · Executive Officer Mark L. Monane · Executive Officer Ajit G. Singh · Director Andrew L. Guggenhime · Director Hongjie G. Hu · Director James R. Tobin · Director Louis G. Lange · Director Patrick G. Enright · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Proceeds will be used for general corporate purposes.”Signed by David Levison, President and CEO. Source: SEC Form D and 1 amendment, newest notice filed Feb 22, 2016. Read the notice at the SEC .
equity SEC Jul 2014 $21 M No. 4 $10 to $50 million 14
Cardiodx Inc.: Raise no. 4, Jul 2014 × Investors in this round 14 investors had bought by the notice of Jul 24, 2014: 14 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $21 M of $25 M offered; $4 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: Sale and issuance of Series DD Preferred Stock and the underlying Common Stock issuable upon conversion thereof. Exemption claimed Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice David L. Levison · Executive Officer, Director Deborah L. Kilpatrick · Executive Officer Douglas T. Ross · Executive Officer Gwen R. Carscadden · Executive Officer Mark T. Monane · Executive Officer Melinda L. Griffith · Executive Officer Robert F. Werner · Executive Officer Ajit G. Singh · Director Andrew L. Guggenhime · Director Brook H. Byers · Director James R. Tobin · Director Louis G. Lange · Director Patrick G. Enright · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Proceeds will be used for general corporate purposes.”Signed by David Levison, President and CEO. Source: SEC Form D, newest notice filed Jul 24, 2014. Read the notice at the SEC .
equity SEC Aug 2012 $31 M No. 3 $10 to $50 million 28
Cardiodx Inc.: Raise no. 3, Aug 2012 × Investors in this round 28 investors had bought by the notice of Aug 31, 2012: 28 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $31 M of $58 M offered; $28 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: Sale and issuance of (i) Series CC-1 Preferred Stock, (ii) Series CC-2 Preferred Stock, and (iii) Common Stock issuable upon conversion of Series CC-1 Preferred Stock and Series CC-2 Preferrred Stock.
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Andrew L. Guggenhime · Executive Officer David Levison · Executive Officer, Director Mark G. Weeks · Executive Officer Steven G. Rosenberg · Executive Officer Ajit Singh · Director Arthur M. Pappas · Director Brook Byers · Director Fred G. Cohen · Director Louis G. Lange · Director Patrick Enright · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Proceeds will be used for general corporate purposes including, but not limited to, executive salaries.”Signed by David Levison, President and CEO. Source: SEC Form D, newest notice filed Aug 31, 2012. Read the notice at the SEC .
equity SEC Feb 2011 $57 M No. 2 $50 to $250 million 17
Cardiodx Inc.: Raise no. 2, Feb 2011 × Investors in this round 17 investors had bought by the notice of Mar 2, 2011: 17 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $57 M of $78 M offered; $21 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them, other: Sale/issuance of (i) Series AA Preferred Stock, (ii) Series BB Preferred Stock, (iii) Warrants, (iv) Series AA Preferred Stock underlying Warrants and (v) Common Stock issuable upon conversion of Seri
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $2,279,507 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Amy G. Paye · Executive Officer David Levison · Executive Officer, Director Mark G. Weeks · Executive Officer Steven G. Rosenberg · Executive Officer Arthur M. Pappas · Director Brook Byers · Director Fred G. Cohen · Director Louis G. Lange · Director Patrick Enright · Director Rafael G. Torres · Director William Ericson · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Total offering and sales amounts assume the exercise of warrants ($3,359,837.00)”On the use of proceeds: “This estimate excludes amounts paid and that may be paid to the law firm which two executive officers were/are affiliated.”Signed by David Levison, President and CEO. Source: SEC Form D, newest notice filed Mar 2, 2011. Read the notice at the SEC .
equity, options SEC May 2010 $35 M No. 1 $10 to $50 million 16
Cardiodx Inc.: Raise no. 1, May 2010 × Investors in this round 16 investors had bought by the notice of May 14, 2010: 16 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $35 M of $45 M offered; $10 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: Sale and Issuance of Series D Preferred Stock and the underlying Common Stock issuable upon conversion thereof
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $723,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Amy G. Paye · Executive Officer David Levison · Executive Officer, Director Jeff G. Heer · Executive Officer Mark G. Weeks · Executive Officer Steven G. Rosenberg · Executive Officer Arthur M. Pappas · Director Brook Byers · Director Fred G. Cohen · Director Louis G. Lange · Director Michael Goldberg · Director Rafael G. Torres · Director Risa Stack · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “This estimate excludes amounts paid and that may be paid to the law firm which two executive officers were/are affiliated and also excludes amounts previously received from the issuance of convertible promissory notes that were converted in the financing.”Signed by David Levison, President and CEO. Source: SEC Form D, newest notice filed May 14, 2010. Read the notice at the SEC .
equity SEC